ProtoKinetix, Inc.
PKTX- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001128189
No open-market purchases or sales by ProtoKinetix, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $200 in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 1
- 13F valueReported value at the end of Q2 2026
- $200
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PKTX, Q2 2026
No superinvestor reported holding PKTX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by ProtoKinetix, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 (view filing)5:10 PM ET | Sep 26 | 1 day | Smith Clarence EdwardPresident & CEO | PPurchase | +2.00M | $0.01 | +$20.0K | +2.9%70.2M after | |
| Jun 17, 2024 (view filing)3:13 PM ET | Jun 13-14 | 4 days | Smith Clarence EdwardPresident & CEO | PPurchase | +6.50M | $0.01 | +$65.0K | +10.5%68.2M after | 2 lots |
| Apr 15, 2024 (view filing)9:45 PM ET | Mar 20-29 | 26 daysLate | Smith Clarence EdwardPresident & CEO | PPurchase | +3.17M | $0.0111 | +$35.0K | +5.4%61.7M after | 2 lots |
| Dec 28, 2023 (view filing)3:14 PM ET | Dec 26 | 2 days | Smith Clarence EdwardPresident & CEO | PPurchase | +7.33M | $0.015 | +$110.0K | +14.3%58.5M after | |
| Oct 27, 2023 (view filing)5:06 PM ET | Oct 26 | 1 day | Guzzetta Michael RichardCFO | PPurchase | +20.0K | $0.0165 | +$330 | +2.8%736.4K after | |
| Aug 30, 2023 (view filing)4:10 PM ET | Aug 29 | 1 day | Smith Clarence EdwardPresident & CEO | PPurchase | +1.50M | $0.02 | +$30.0K | +3.0%51.2M after | |
| Jun 15, 2023 (view filing)3:55 PM ET | Jun 15 | Same day | Smith Clarence EdwardPresident & CEO | PPurchase | +2.00M | $0.02 | +$40.0K | +4.2%49.7M after | |
| May 24, 2023 (view filing)4:23 PM ET | May 22 | 2 days | Smith Clarence EdwardPresident & CEO | PPurchase | +3.75M | $0.02 | +$75.0K | +8.5%47.7M after | |
| Jan 31, 2023 (view filing)6:30 PM ET | Jan 23 | 8 daysLate | Smith Clarence EdwardPresident & CEO | PPurchase | +2.00M | $0.02 | +$40.0K | +4.8%44.0M after | |
| Jan 4, 2023 (view filing)6:03 PM ET | Dec 14-21, 2022 | 21 daysLate | Smith Clarence EdwardPresident & CEO | PPurchase | +337.5K | $0.0292 | +$9.87K | +2.5%13.6M after | 4 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in ProtoKinetix, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Williams Jones Wealth Management, LLC. | 20,000 | $200 | 0.00% | 00.0% | Unchanged |